Evidence map›Paper›PMID 23872679›Full record

ArticleNature immunology2013

Structural basis of a unique interferon-β signaling axis mediated via the receptor IFNAR1.

Nicole A de Weerd, Julian P Vivian, Thao K Nguyen, Niamh E Mangan, Jodee A Gould, Susie-Jane Braniff, Leyla Zaker-Tabrizi, Ka Yee Fung, Samuel C Forster, Travis Beddoe and 3 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06510426 (Early Interferon-beta Treatment for West-Nile Virus Infection), which is not on this map. Cited by 164 papers.

0numbers the graph read from it
0cells of the map it votes in
164citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06510426 phase2unknown statusnot on this mapstarted 2024, after this paper: background citation

Early Interferon-beta Treatment for West-Nile Virus Infection

TypeinterventionalSponsorTel-Aviv Sourasky Medical CenterRan2024 to 2025Enrolled100ConditionsWest Nile Virus, West Nile Fever Encephalitis, West Nile Fever Myelitis, West Nile Fever With Other ComplicationsArmsRebif 44 MCG Per 0.5 ML Prefilled Syringe, Saline
3 · Its place in the literature

Who cites it

164 citing papers in PubMed, 254 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Itaconate modifications: Mechanisms and applications.Journal of intensive medicine · 2026
    Review
  6. Article
  7. IFNIKB: a type I interferon database for antitumuor immunity studies.Database : the journal of biological databases and curation · 2026
    Article
  8. Review
  9. Frontiers in immunology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

104 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Nicole A de WeerdCentre for Innate Immunity and Infectious Diseases, Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia.
Julian P Vivian
Thao K Nguyen
Niamh E Mangan
Jodee A Gould
Susie-Jane Braniff
Leyla Zaker-Tabrizi
Ka Yee Fung
Samuel C Forster
Travis Beddoe
Hugh H Reid
Jamie Rossjohn
Paul J Hertzog
Monash Institute of Medical Research · AUMonash University · AUCardiff University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I interferons are important in regulating immune responses to pathogens and tumors. All interferons are considered to signal via the heterodimeric IFNAR1-IFNAR2 complex, yet some subtypes such as interferon-β (IFN-β) can exhibit distinct functional properties, although the molecular basis of this is unclear. Here we demonstrate IFN-β can uniquely and specifically ligate to IFNAR1 in an IFNAR2-independent manner, and we provide the structural basis of the IFNAR1-IFN-β interaction. The IFNAR1-IFN-β complex transduced signals that modulated expression of a distinct set of genes independently of Jak-STAT pathways. Lipopolysaccharide-induced sepsis was ameliorated in Ifnar1(-/-) mice but not Ifnar2(-/-) mice, suggesting that IFNAR1-IFN-β signaling is pathologically relevant. Thus, we provide a molecular basis for understanding specific functions of IFN-β.

Indexed as

Signal TransductionAnimalsDisease Models, AnimalFemaleInterferon-betaLipopolysaccharidesMiceMice, KnockoutModels, MolecularMultiprotein ComplexesProtein BindingProtein ConformationProtein StabilityReceptor, Interferon alpha-betaShock, SepticInterferon-betaLipopolysaccharidesMultiprotein ComplexesReceptor, Interferon alpha-beta

Identifiers

PMID23872679
OpenAlexW2038139581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.